Note
14 – Net Loss Per Share
The
following table summarizes the number of potentially dilutive common stock equivalents excluded from the calculation of diluted net loss
per common share as of December 31, 2022 and 2021. Warrants exercisable for nominal consideration are included in the number of common shares outstanding to calculate
net loss per common share.
Schedule
of Dilutive Net Loss Per Common Share
| |
2022 | | |
2021 | |
| |
December 31, | |
| |
2022 | | |
2021 | |
Shares of common stock issuable upon exercise of warrants | |
| 4,593,000 | | |
| 4,553,000 | |
Shares of common stock issuable upon exercise of options and restricted stock units | |
| 4,194,000 | | |
| 3,844,000 | |
Potentially dilutive common stock equivalents excluded from diluted net loss per share | |
| 8,787,000 | | |
| 8,397,000 | |
Anti-dilutive common shares | |
| 8,787,000 | | |
| 8,397,000 | |
|